chr16-69330428-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_022341.2(PDF):​c.143A>G​(p.Tyr48Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000129 in 1,475,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

PDF
NM_022341.2 missense

Scores

3
3
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.55

Publications

0 publications found
Variant links:
Genes affected
PDF (HGNC:30012): (peptide deformylase, mitochondrial) Protein synthesis proceeds after formylation of methionine by methionyl-tRNA formyl transferase (FMT) and transfer of the charged initiator f-met tRNA to the ribosome. In eubacteria and eukaryotic organelles the product of this gene, peptide deformylase (PDF), removes the formyl group from the initiating methionine of nascent peptides. In eubacteria, deformylation of nascent peptides is required for subsequent cleavage of initiating methionines by methionine aminopeptidase. The discovery that a natural inhibitor of PDF, actinonin, acts as an antimicrobial agent in some bacteria has spurred intensive research into the design of bacterial-specific PDF inhibitors. In human cells, only mitochondrial proteins have N-formylation of initiating methionines. Protein inhibitors of PDF or siRNAs of PDF block the growth of cancer cell lines but have no effect on normal cell growth. In humans, PDF function may therefore be restricted to rapidly growing cells. [provided by RefSeq, Nov 2008]
COG8 (HGNC:18623): (component of oligomeric golgi complex 8) This gene encodes a protein that is a component of the conserved oligomeric Golgi (COG) complex, a multiprotein complex that plays a structural role in the Golgi apparatus, and is involved in intracellular membrane trafficking and glycoprotein modification. Mutations in this gene cause congenital disorder of glycosylation, type IIh, a disease that is characterized by under-glycosylated serum proteins, and whose symptoms include severe psychomotor retardation, failure to thrive, seizures, and dairy and wheat product intolerance. [provided by RefSeq, Jul 2008]
COG8 Gene-Disease associations (from GenCC):
  • COG8-congenital disorder of glycosylation
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.759

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDFNM_022341.2 linkc.143A>G p.Tyr48Cys missense_variant Exon 1 of 2 ENST00000288022.2 NP_071736.1 Q9HBH1A0A024R6Y3
COG8NM_032382.5 linkc.*26+385A>G intron_variant Intron 5 of 5 ENST00000306875.10 NP_115758.3 Q96MW5A0A024R6Z6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDFENST00000288022.2 linkc.143A>G p.Tyr48Cys missense_variant Exon 1 of 2 1 NM_022341.2 ENSP00000288022.1 Q9HBH1
COG8ENST00000306875.10 linkc.*26+385A>G intron_variant Intron 5 of 5 1 NM_032382.5 ENSP00000305459.6 Q96MW5B4DYU2
ENSG00000272617ENST00000562949.1 linkc.352-1249A>G intron_variant Intron 1 of 1 3 ENSP00000457718.1 H3BUN2
COG8ENST00000562595.5 linkc.548+4898A>G intron_variant Intron 3 of 3 5 ENSP00000456705.1 H3BSH5

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151832
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000255
AC:
2
AN:
78442
AF XY:
0.0000221
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000132
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000128
AC:
17
AN:
1324094
Hom.:
0
Cov.:
32
AF XY:
0.0000107
AC XY:
7
AN XY:
653124
show subpopulations
African (AFR)
AF:
0.0000375
AC:
1
AN:
26692
American (AMR)
AF:
0.0000750
AC:
2
AN:
26680
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23344
East Asian (EAS)
AF:
0.0000350
AC:
1
AN:
28604
South Asian (SAS)
AF:
0.0000136
AC:
1
AN:
73438
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32890
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3910
European-Non Finnish (NFE)
AF:
0.0000114
AC:
12
AN:
1053616
Other (OTH)
AF:
0.00
AC:
0
AN:
54920
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151832
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74158
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41396
American (AMR)
AF:
0.00
AC:
0
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10510
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67908
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.600
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000453

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 02, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.143A>G (p.Y48C) alteration is located in exon 1 (coding exon 1) of the PDF gene. This alteration results from a A to G substitution at nucleotide position 143, causing the tyrosine (Y) at amino acid position 48 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.15
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.041
T
Eigen
Benign
0.17
Eigen_PC
Benign
0.093
FATHMM_MKL
Benign
0.48
N
LIST_S2
Benign
0.62
T
M_CAP
Pathogenic
0.91
D
MetaRNN
Pathogenic
0.76
D
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
0.90
L
PhyloP100
1.6
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.24
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.013
D
Polyphen
1.0
D
Vest4
0.46
MutPred
0.44
Gain of catalytic residue at W49 (P = 0.0025);
MVP
0.85
MPC
1.3
ClinPred
0.26
T
GERP RS
2.8
PromoterAI
-0.046
Neutral
Varity_R
0.24
gMVP
0.61
Mutation Taster
=56/44
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs948791022; hg19: chr16-69364331; API